Public Release:  Philippe Généreux, MD, presented with 2012 TCT Young Investigator Award

Prize honors clinical and academic excellence of promising investigators

Cardiovascular Research Foundation

MIAMI, FL - OCTOBER 26, 2012 - Philippe Généreux, MD was presented the TCT 2012 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The award is given each year to a promising researcher in the field of interventional cardiovascular medicine. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiology.

The award honors the memory of Thomas J. Linnemeier, MD, the former chief of the Indiana Heart Institute, senior vice president of New Ventures, and chief medical officer of Vascular Intervention at Guidant Corp. The purpose of the award, which is accompanied by a $10,000 grant, is to encourage the recipient to maintain a continued commitment and dedication to both patient care and academic research.

An outstanding young academician and a prolific writer, Dr. Philippe Généreux is a practicing Interventional Cardiologist at Hôpital du Sacré-Coeur de Montréal. Dr. Généreux also serves as the Director of the Angiographic Core Laboratory at the CRF Clinical Trials Center where he leads the lab's coronary, peripheral, and structural imaging analyses and services. He received his medical degree from the Université de Montréal, Québec, Canada, and is currently pursuing a PhD at Erasmus University in Rotterdam, The Netherlands. His research interests include coronary risk stratification/Syntax score, coronary physiology and imaging, percutaneous aortic valve replacement, transradial intervention, drug-eluting stent innovation, and medical simulation.

The winner was selected by Drs. Sheldon Goldberg, Howard C. Herrmann, John W. Hirshfeld Jr. and Robert L. Wilensky from Philadelphia. Gregg W. Stone, MD and Howard C. Hermann, MD jointly presented the award. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Herrmann is Professor of Medicine and the Director of Interventional Cardiology and Cardiac Catheterization Labs at the Hospital of the University of Pennsylvania.

"Dr. Généreux's tireless commitment to the dual tracks of cardiovascular research and patient care have established him as a rising star in the field, and he is well on his way to becoming a future leader in interventional cardiology," said Drs. Stone and Herrmann.

"We are extremely proud to honor Dr. Philippe Généreux with the TCT 2012 Young Investigator Award for his exceptional academic achievements and superb clinical skills, as well as his dedication and passion for the field," Martin B. Leon, MD added. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Drs. Leon and Stone both serve as Co-Directors of the Medical Research and Education Division at CRF, and direct the annual TCT scientific sessions.

###

The other finalists for the Young Investigator Award were Ehrin J. Armstrong, MD, MSc from the University of California, Davis Medical Center and Giulio G. Stefanini, MD from Bern University Hospital in Switzerland.

Previous winners of the TCT Young Investigator Award include: David E. Kandzari, MD; Farouc Jaffer, MD, PhD; Giuseppe De Luca, MD; Alaide Chieffo, MD; Wojciech Wojakowski, MD, PhD; Mehdi H. Shishehbor, DO, MPH; Robert A. Byrne, MD; Colin M. Barker, MD; Davide Capodanno, MD; and Robert W. Yeh, MD.

About CRF

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of the Cardiovascular Research Foundation. TCT gathers leading medical researchers and clinicians from around the world to present and discuss the latest developments in the field.

For more information, visit www.crf.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.